TopOnwardTicket Launches Onward Ticket and Dummy Ticket Services for International Travelers

TopOnwardTicket, an online travel documentation platform, has announced the launch of its Onward Ticket and Dummy Ticket services designed to help international travelers meet visa and immigration requirements quickly and

Read More

Picketing Is Building an AI Agent That Manages Ad Campaigns So Brands Don’t Have To

Korea-based AI startup Picketing’s reinforcement learning-powered platform, PICKY, automates multi-platform ad optimization for small businesses with a single click. The digital advertising landscape has become a labyrinth for small and

Read More

Product Information Management Market to Reach $37.39 Billion by 2031 Amid AI-Driven Catalog Automation & Omnichannel Expansion

Product Information Management Market Mordor Intelligence has published a new report on the product information management market, offering a comprehensive analysis of trends, growth drivers, and future projections Product Information

Read More

IKAN Health Recognizes CoreAge Rx as the Best GLP-1 Brand for Patients Without Insurance, Citing No Waitlist Policy and Free 2-Day Shipping as Standout Features

Independent health publication highlights CoreAge Rx’s physician-supervised telehealth model, rapid medication access, and transparent treatment pathway for medically supervised weight management. IKAN Health, an independent health and wellness publication focused

Read More

Duchenne Muscular Dystrophy Clinical Pipeline Accelerates: Over 75 Companies Advancing Next-Generation Therapies | DelveInsight

Duchenne Muscular Dystrophy Companies Duchenne Muscular Dystrophy Companies include Santhera Pharmaceuticals, Sarepta Therapeutics, Italfarmaco, Wave Life Sciences Ltd, FibroGen, EDG 5506 Edgewise Therapeutics, Fordadistrogene movaparvovec, Daiichi Sankyo, Sarepta Therapeutics, Inc.,

Read More

IZERVAY Market to Witness Robust Growth Through 2034 Driven by Rising Geographic Atrophy Treatment Adoption, Strong Clinical Outcomes, and Expanding Global Footprint | DelveInsight

IZERVAY Market IZERVAY sales market forecast report provides a detailed market assessment of IZERVAY for approved indication like Dry age-related macular degeneration; as well as potential inidcations like Polypoidal choroidal

Read More

Ablation Devices Market to Reach USD 15.34 Billion by 2034, Growing at a CAGR of 8.38% Driven by Rising Chronic Disease Burden and Advancements in Minimally Invasive Technologies | DelveInsight

Ablation Devices Market Ablation Devices companies include Medtronic, Boston Scientific Corporation, Abbott, Johnson & Johnson Services Inc, AtriCure, Inc., Stryker, Smith & Nephew, Hologic, Inc., CONMED Corporation., Biotronik SE &

Read More

Psoriasis Treatment Market to Surpass USD 57 Billion by 2034, Growing at a CAGR of 5.41% | DelveInsight

Psoriasis Treatment Market Psoriasis treatment companies include Galderma, Johnson & Johnson Services, Inc., Amgen Inc., AstraZeneca, Bausch Health Companies Inc., Pfizer Inc., GSK plc., Astellas Pharma Inc., Teva Pharmaceutical Industries

Read More

Cerebrospinal Fluid Management Market to Reach USD 1,001.28 Million by 2032, Growing at a CAGR of 5.18% | DelveInsight

Cerebrospinal Fluid Management Market Cerebrospinal fluid management companies include Medtronic, B. Braun Melsungen AG, Neuromedex GmbH, Natus Medical Incorporated, Sophysa, Integra LifeSciences Corporation, Spiegelberg GmbH & Co. KG, Desu Medical,

Read More

Polysomnography Devices Market to Reach USD 392.05 Million by 2032, Growing at a CAGR of 5.02% | DelveInsight

Polysomnography Devices Market Leading Polysomnography Devices companies such as Koninklijke Philips N.V., Compumedics Limited, Natus Medical Incorporated, Nox Medical, ResMed, and others. The global healthcare landscape is witnessing a paradigm

Read More

Hodgkin’s Lymphoma Pipeline Expands as 15+ Pharma Companies Advance 20+ Novel Therapies Toward Market Entry, Finds DelveInsight

Hodgkin’s Lymphoma – Pipeline Insight, 2026 DelveInsight’s “Hodgkin’s Lymphoma – Pipeline Insight, 2026” report provides comprehensive insights about 15+ companies, including Merck Sharp & Dohme LLC, Affimed Therapeutics, Aurigene Oncology,

Read More

Novartis’s COSENTYX (Secukinumab) Approved by the FDA for Pediatric Hidradenitis Suppurativa: Only IL-17A Inhibitor Cleared for Adolescents Aged 12+

Novartis’s COSENTYX (Secukinumab) Approved by the FDA for Pediatric Hidradenitis Suppurativa DelveInsight Analysis: What Novartis’s COSENTYX (Secukinumab) Approval by the FDA for Pediatric Hidradenitis Suppurativa Means for the Hidradenitis Suppurativa

Read More

Mammography Devices Market Poised for Robust Growth at 8.25% CAGR Through 2034: DelveInsight | Hologic, GE Healthcare, and Siemens Healthineers

Mammography devices market The global mammography devices market is set for strong, sustained expansion, driven by companies such as, SternMed GmbH, FUJIFILM Corporation, Hologic Inc., Planmed OY, General Electric Company

Read More

Fetal Monitoring Devices Market Set for Steady Growth at 6.34% CAGR Through 2034: DelveInsight | Philips, GE Healthcare, and Natus Medical

Fetal monitoring devices market Insights The global fetal monitoring devices market is set for strong, sustained expansion, driven by companies such as General Electric Company (GE Healthcare), Koninklijke Philips N.V.,

Read More

Cutaneous Lupus Erythematosus Clinical Trial Pipeline Accelerates as 10+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s, “Cutaneous Lupus Erythematosus Pipeline Insight 2026” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Cutaneous Lupus Erythematosus pipeline landscape. It covers the Cutaneous Lupus Erythematosus

Read More

HER2 Positive Breast Cancer Clinical Trial Pipeline Appears Robust With 50+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s, “HER2 Positive Breast Cancer Pipeline Insight, 2026” report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in HER2 Positive Breast Cancer pipeline landscape. It covers the HER2

Read More

Acute Myeloid Leukemia Clinical Trial Pipeline Shows Potential with Active Contributions from 100+ Key Companies | DelveInsight

DelveInsight’s “Acute Myeloid Leukemia Pipeline Insights 2026” report provides comprehensive insights about 100+ companies and 110+ pipeline drugs in Acute Myeloid Leukemia pipeline landscape. It covers the Acute Myeloid Leukemia

Read More

HDAC inhibitors Clinical Trial Pipeline Appears Robust With 40+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s, “HDAC Inhibitor Pipeline Insights 2026” report provides comprehensive insights about 40+ companies and 50+ pipeline drugs in HDAC Inhibitor pipeline landscape. It covers the HDAC Inhibitor pipeline drug profiles,

Read More

Follicular Lymphoma Treatment Pipeline Shows Strong Momentum as 45+ Pharma Companies in the Race | DelveInsight

DelveInsight’s, “Follicular Lymphoma Pipeline Insight, 2026” report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in Follicular Lymphoma pipeline landscape. It covers the Follicular Lymphoma pipeline drug profiles,

Read More

Esophageal Squamous Cell Carcinoma Clinical Trial Pipeline Shows Potential with Active Contributions from 50+ Key Companies | DelveInsight

DelveInsight’s, “Esophageal Squamous Cell Carcinoma Pipeline Insights 2026” report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Esophageal Squamous Cell Carcinoma pipeline landscape. It covers the Esophageal

Read More